by
The global veterinary drugs compounding market is estimated to be valued at US$ 1,179.7 Mn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The veterinary drugs compounding market refers to the customization of medications specifically for animals. This process involves combining or altering pharmaceutical ingredients to create dosage forms that are suitable for individual animals. Customized medications are often necessary for animals that have specific dosage needs or are unable to take commercially available medications. Veterinary drugs compounding allows for precise dosage and delivers medication in forms that animals find easier to ingest, such as flavored treats or liquid suspensions. This market primarily serves veterinarians and pet owners who require medication options tailored to their animal’s needs.
Market Key Trends:
One key trend observed in the veterinary drugs compounding market is the increasing demand for customized medications for companion animals. As more pet owners prioritize the health and well-being of their pets, there is a growing demand for medications that are tailored to address specific conditions or dosage requirements. The customization of medications allows veterinarians to effectively treat animals with unique needs, such as those with allergies to certain ingredients or those requiring smaller or larger doses than commercially available options. The ability to provide personalized medications not only improves patient care but also enhances owner satisfaction and compliance with treatment plans. This trend is expected to drive the growth of the veterinary drugs compounding market in the coming years.
PEST Analysis:
Political: In the Veterinary Drugs Compounding Market Size, political factors have a significant impact on regulations and policies related to animal healthcare. Government regulations regarding drug manufacturing, licensing, and veterinary practices can affect the compounding market. For instance, regulatory bodies may impose stringent guidelines for drug compounding to ensure quality and safety.
Economic: The economic factors affecting the veterinary drugs compounding market include the cost of raw materials, availability of veterinary drugs, and affordability for pet owners. The market growth is also influenced by macroeconomic factors such as GDP growth, inflation rates, and disposable income, as they determine the spending capacity of pet owners on veterinary drugs.
Social: Social factors that impact the veterinary drugs compounding market involve changing pet ownership patterns, increasing awareness about pet healthcare, and humanization of pets. With a growing focus on pet welfare and personalized medication, the demand for customized compounded veterinary drugs is on the rise. Additionally, cultural attitudes towards pets and the role of animals in society can influence the market dynamics.
Technological: Technological advancements play a vital role in the veterinary drugs compounding market. Innovation in drug compounding techniques, such as pharmaceutical compounding robots and automated systems, can enhance efficiency, accuracy, and safety. Advancements in telemedicine and digital health platforms also facilitate remote consultations and drug prescription, impacting the compounding market.
Key Takeaways:
The global veterinary drugs compounding market is expected to witness high growth, exhibiting a CAGR of 5.5% over the forecast period (2021-2028), primarily driven by increasing pet adoption and companion animal healthcare expenditure. The market size is estimated to reach US$ 1,179.7 million in 2021.
In terms of regional analysis, North America is expected to be the fastest-growing and dominating region in the veterinary drugs compounding market. The region’s growth can be attributed to factors such as a large pet population, high disposable income, and a well-established veterinary healthcare infrastructure.
Key players operating in the veterinary drugs compounding market include Wedgewood Pharmacy, Pace Pharmacy, Tache Pharmacy, The Pet Apothecary, Pet Script, Golden Gate Veterinary Compounding Pharmacy, CareFirst Specialty Pharmacy, Triangle Compounding Pharmacy, Miller’s Pharmacy, and Davis Islands Pharmacy. These players contribute to the market through their expertise in compounding veterinary drugs and a wide range of product offerings.
Overall, the veterinary drugs compounding market is driven by political, economic, social, and technological factors. The market’s growth potential lies in the adoption of advanced technologies, increased awareness about personalized pet healthcare, and favorable government regulations. The key players in the market play a pivotal role in meeting the growing demand for compounded veterinary drugs.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
